• Nenhum resultado encontrado

[PDF] Top 20 Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Has 10000 "Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin" found on our website. Below are the top 20 most common "Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin".

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

... inhibitor, dapagliflozin, and the dipeptidyl peptidase-4 (DPP4) inhibitor, saxagliptin, both added on to ...of patients with type 2 diabetes (T2D) ... See full document

7

Arq Bras Endocrinol Metab  vol.55 número4

Arq Bras Endocrinol Metab vol.55 número4

... function in patients with type 2 diabetes by increasing both α- and b-cells responsiveness to gluco- se ...combined with metformin (12,13). Recent studies have ... See full document

6

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

... sulphonylurea versus sulphonylurea alone) is what makes our meta-analysis ...contradictory with those of previous systematic reviews ...analyse metformin only as a ...from metformin—of UKPDS ... See full document

10

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

... evening. Saxagliptin was to be taken in the morning. Patients were eligible for rescue therapy based on progressively strict glycaemic control criteria over 24 weeks if MFPG levels ... See full document

12

Effect of treatment with sitagliptin on somatosensoryevoked potentials and metabolic control in patients with type 2 diabetes mellitus

Effect of treatment with sitagliptin on somatosensoryevoked potentials and metabolic control in patients with type 2 diabetes mellitus

... Objetivo: Avaliar o efeito da sitagliptina nos potenciais evocados somatossensoriais (PESS) e controle metabólico de pacientes com diabetes melito tipo 2, sem neuropatia diabética. Mate- riais e métodos: ... See full document

8

Low Serum Testosterone Concentrations in Hospitalized Men with Poorly Controlled Type 2 Diabetes

Low Serum Testosterone Concentrations in Hospitalized Men with Poorly Controlled Type 2 Diabetes

... immunoassay with an Architect i1000 immunol- ogy analyzer (Abbott Laboratories, North Chicago, IL, ...determined with a Cobas 6000 analyzer (Roche, Mannheim, ...based on mass action laws using ... See full document

5

Prediction of morbidity and mortality in patients with type 2 diabetes

Prediction of morbidity and mortality in patients with type 2 diabetes

... of patients with type 2 diabetes have been shown to predict poorly when applied to patients with diabetes (Sheridan, Pignone & Mulrow, 2003; Guzder et ...for ... See full document

13

Rev. Assoc. Med. Bras.  vol.58 número3 en v58n3a08

Rev. Assoc. Med. Bras. vol.58 número3 en v58n3a08

... +/-15% on all selected ...that patients will remain under treatment with SAX or TZDs. In proba- bilistic analyses, adding SAX to the MF therapy was domi- nant in ...scenarios ... See full document

8

Clinics  vol.64 número5

Clinics vol.64 número5

... activation in the context of metabolic disorders and their responses to ...the metformin group exhibited a higher insulin sensitivity as assessed by indirect measures at baseline compared to ... See full document

6

Rev. Bras. Psiquiatr.  vol.32 número2

Rev. Bras. Psiquiatr. vol.32 número2

... Memantine, a drug approved by the FDA for the treatment of moderate to severe Alzheimer’s disease, acts as weak non-selective NMDA receptor antagonist. Our group conducted the first randomized placebo-controlled ... See full document

3

Rev. LatinoAm. Enfermagem  vol.16 número2

Rev. LatinoAm. Enfermagem vol.16 número2

... of type 2 diabetic patients through sociodemographic data, habits of health, anthropometric and biochemist profiles, assisted at a basic public health care unit in Maringá, ...Sixty-six ... See full document

7

Rev. LatinoAm. Enfermagem  vol.24

Rev. LatinoAm. Enfermagem vol.24

... Initially, type 2 diabetes impacted more the rich countries, but with globalization it reached all ...behavior, in type 2 diabetes is associated with social ... See full document

2

RGO, Rev. Gaúch. Odontol.  vol.63 número4

RGO, Rev. Gaúch. Odontol. vol.63 número4

... role in immune and inlammatory responses and the balance between them can determine the outcome of periodontal ...change in the pattern of inlammatory response can be explained as an attempt by the ... See full document

7

DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN  TYPE 2 DIABETES

DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES

... Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, which contributes to micro and macrovascular complications including retinopathy, neuropathy and accelerated cardiovascular ... See full document

2

Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis

Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis

... testing. In the present investigation, the fact that only the hypertonic Sabouraud broth test 49 was performed for the discrimination between these 2 species may be considered as a limitation of this ... See full document

8

Daytime sleepiness in patients with type 2 Diabetes Mellitus : a prospective cohort study

Daytime sleepiness in patients with type 2 Diabetes Mellitus : a prospective cohort study

... tested with the Levene’s test and normality was tested with the Shapiro-Wilk ...data with equal variances were performed to compare between cases with and without excessi- ve daytime ...was ... See full document

10

Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

... that in humans is primarily secreted by the macrophages [9,10] embed- ded in the adipose tissue—which has been implicated in cardiovascular disease and atherogen- esis ...described in the ... See full document

9

Association between polypharmacy and the adherence to  treatment in patients with diabetes

Association between polypharmacy and the adherence to treatment in patients with diabetes

... com diabetes mellitus tipo ...de diabetes mellitus tipo 2 por meio de entrevista sobre os dados sociodemográficos e clínicos, a terapêutica medicamentosa prescrita e a adesão ao ... See full document

8

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.

... the patients. The excellent cooperation with the clinical chemical laboratory (head of department: ...Clinics in Zwolle, The Netherlands, is acknowledged as ...assistance in CE-MS ... See full document

10

Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients

Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients

... analyzed with the Statistical Package for Social Sci- ence for Windows, version ...recent-onset type 1 diabe- tes patients, 28 ...duration type 1 diabetes subjects, 20 ... See full document

4

Show all 10000 documents...